Dr. Raye Litten is the Acting Director of the Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism (NIAAA). Dr. Litten manages the NIAAA medications development program to treat alcohol use disorder (AUD). He oversees the development of medications for AUD that are efficacious and safe by translating neuroscience discoveries into lead compounds and advancing them through drug development pipeline. Finally, he also serves as the Project Officer for the NIAAA NCIG clinical trials program and served as Project Officer on the multi-site Phase 3 clinical trial COMBINE. Dr. Litten is the author of over 110 publications and co-editor of 9 books and journals.